BIIB Biogen Inc

  • BIIB
  • Price as of: Jan 23, 04:00 PM EST
  • $276.02
  • -$4.64
  • -1.7%
  • Industry
  • Drug manufacturers - major

BIIB Stock Dividend Data

Add BIIB to Watchlist
  • Dividend Yield
    0.00% Healthcare Average 0.91%
  • Annualized Payout
  • Payout Ratio
    0.0% EPS $20.18
  • Dividend Growth
    No Payout Increase Last Year
  • Get BIIB DARS™ Rating

Looking to buy or sell BIIB?

Buy Now
Sell Now
Upcoming Dividend Payouts

BIIB Upcoming Dividend Payouts

BIIB has not yet officially announced its next dividend payout.
DARS Rating™ Breakdown DARS Rating™ Breakdown for BIIB

Metric Ranking Avg Ranking Notes
Stock not rated.
Yield History

BIIB Dividend Yield & Stock Price History

Dividend Payout History

BIIB Dividend Payout History

No Payout History Is Available

Brought to You by Mitre Media

Growth History

BIIB Dividend Growth History

Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Years of
Reveal More Dividend Growth History for BIIB
Historical Annual Dividend Data & Growth

BIIB Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
No Payout History Is Available
Historical Dividend Data

BIIB Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
No Payout History Is Available

Knowledge Centers

Company Profile

BIIB Company Profile

Exchange: NASDAQ
Sector: Healthcare

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks

Biogen Inc News

  • The analysts here at analyzed the search patterns of visitors to our site during the past week ending October 2, 2015. Below we give an analysis of how intelligently users used to help them in their investment...

  • Some investors prefer the growth aspect of share buybacks, while others won’t even think about investing in stocks without a dividend payment. While each side tends to hold a rigid view, there are merits of each strategy. Both dividends and share...

  • When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development....

  • We are just a touch off earlier lows, but the trends in names we talked about earlier is still persisting. Let's check out how the last hour is...
  • Market averages are still higher, but volume is pretty abysmal as we head into the last hour of trading. Not a lot has changed in the last few...
  • The markets are starting to catch fire after the slow start at the open. Fund managers squeeze in some last-minute buying as the quarter wraps up...
  • Here we go! A short trading week and a small move higher at the open. Let's take a look at what I have on the radar this morning. Story...